Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
UBS
Healthtrust
Accenture
Moodys
Federal Trade Commission
Citi
AstraZeneca
Novartis

Generated: August 18, 2017

DrugPatentWatch Database Preview

PRINCIPEN Drug Profile

« Back to Dashboard

Which patents cover Principen, and what generic Principen alternatives are available?

Principen is a drug marketed by Apothecon and Bristol Myers Squibb and is included in nine NDAs.

The generic ingredient in PRINCIPEN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.

Summary for Tradename: PRINCIPEN

Patents:0
Applicants:2
NDAs:9
Bulk Api Vendors: see list29
Patent Applications: see list9,800
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRINCIPEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
PRINCIPEN
ampicillin/ampicillin trihydrate
CAPSULE;ORAL062888-001Mar 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PRINCIPEN
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL061394-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
PRINCIPEN
ampicillin/ampicillin trihydrate
CAPSULE;ORAL061392-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PRINCIPEN '250'
ampicillin/ampicillin trihydrate
CAPSULE;ORAL050056-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PRINCIPEN '125'
ampicillin/ampicillin trihydrate
FOR SUSPENSION;ORAL060127-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Baxter
US Department of Justice
Fish and Richardson
Deloitte
McKesson
Federal Trade Commission
Express Scripts
Moodys
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot